Carcinogenesis Advance Access published online on September 6, 2006
Carcinogenesis, doi:10.1093/carcin/bgl170
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 National Institute of Occupational Health, Copenhagen, Denmark; Institute of Life Sciences and Chemistry, Roskilde University, Roskilde
* To whom correspondence should be addressed. Use of NSAIDs has been associated with decreased risk of breast cancer in epidemiological studies. Thus, a high inflammatory response may be associated with increased breast cancer risk. It is thus possible that genetic variations leading to a modified inflammatory response will influence breast cancer risk. The purpose of this study was to determine if polymorphisms associated with an altered inflammatory response are associated with breast cancer risk, and to investigate the possible interaction with lifestyle factors such as alcohol use, smoking and NSAID use. We matched 361 female breast cancer cases with 361 controls, nested within the prospective "Diet, Cancer and Health" study. Carriers of the variant Ala-allele of PPAR
Received April 18, 2006
Revised August 29, 2006
Accepted September 2, 2006
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
Peroxisome profilerator-activated receptor
Ulla Vogel 1 *, Jane Christensen 2, Bjørn A. Nexø 3, Håkan Wallin 4, Søren Friis 2, and Anne Tjønneland 2
2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes
2 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
3 Institute of Human Genetics, University of Aarhus, Aarhus, Denmark
4 National Institute of Occupational Health, Copenhagen, Denmark
Ulla Vogel, E-mail: ubv{at}ami.dk
![]()
Abstract
2Pro12Ala were at lower risk of breast cancer (IRR=0.67, 95%CI=0.46-0.97). This was primarily due to an interaction with alcohol consumption. Alcohol consumption was associated with a 1.21-fold increased risk of breast cancer pr 10 g alcohol/day (95% CI= 1.06-1.35) among homozygous wild type carriers, whereas alcohol was not associated with breast cancer risk among variant allele carriers (P for interaction=0.005). NSAID users, who were carriers of the variant allele of PPAR
2Pro12Ala, were at lower risk of breast cancer (IRR = 0.44; 95%CI=0.26-0.73) compared with non-users carrying wildtype alleles (P for interaction=0.03). No effects were found for IL6 G-174C, IL8 T-251A and COX2 T8473C. Our results suggest that PPAR
2Pro12Ala is an important determinant in alcohol mediated breast carcinogenesis. We also observe interaction between NSAID, alcohol consumption and PPAR
2Pro12Ala genotype in relation to breast cancer risk.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Ondrey Peroxisome Proliferator-Activated Receptor {gamma} Pathway Targeting in Carcinogenesis: Implications for Chemoprevention Clin. Cancer Res., January 1, 2009; 15(1): 2 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Venkata, C. S. Aung, P. J. Cabot, G. R. Monteith, and S. J. Roberts-Thomson PPAR{alpha} and PPAR{beta} Are Differentially Affected by Ethanol and the Ethanol Metabolite Acetaldehyde in the MCF-7 Breast Cancer Cell Line Toxicol. Sci., March 1, 2008; 102(1): 120 - 128. [Abstract] [Full Text] [PDF] |
||||

